Dr. Ehrlich is a clinician-scientist specializing in epidemiologic and health services research and the clinical care of patients with glaucoma, cataract, and anterior segment disease. He completed his undergraduate education at Washington University in St. Louis, studying anthropology and Spanish. He attended medical school at Cornell University, graduating with honors in research, and he earned a Master’s of Public Health from Columbia University, where his studies focused on epidemiology. He completed a residency in ophthalmology at Wills Eye Hospital, followed by a clinical fellowship in glaucoma and anterior segment disease and a research fellowship, both at University of Michigan. Dr. Ehrlich’s research is funded by the National Institutes of Health, as well as various private foundations, and is focused on addressing the adverse impact of vision impairment on health, disability, and quality-of-life, with a particular focus on older adults. Dr. Ehrlich serves as an invited member of the Lancet Global Health Commission on Global Eye Health, the Advisory Board for the Center for Vision and Population Health at Prevent Blindness, the editorial board of Ophthalmic Epidemiology, and the Vision Loss Experts Group, a technical advisory group to the World Health Organization and Global Burden of Disease project. He is also a Co-Director of the Kellogg Eye Center for International Ophthalmology where his global health work is focused on research collaborations, research capacity building, and strengthening eye care delivery systems globally.